Apellis Pharmaceuticals (APLS) Q1 2026 Earnings

May 7Confirmed
Q3 2025
Q4 2025
Q1 2026
Q1 2026
-0.47
0.24
0.96
1.67

Details

Expected EPS
-0.37
Actual EPS
0.15
Surprise EPS
0.52
Surprise Percent
+140.54%

Description

⁨Apellis Pharmaceuticals⁩ (⁦APLS⁩) has reported earnings of ⁦0.15⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts